Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

serum C-reactive protein (CRP) levels

Outcome Time Frame:

6 months

Safety Issue:

No

Authority:

Poland: Ethics Committee

Study ID:

POLovaRIS

NCT ID:

NCT01798875

Start Date:

April 2012

Completion Date:

December 2015

Related Keywords:

• PCOS
• pcos
• metformin
• oral contraception
• cyproterone acetate
• Polycystic Ovary Syndrome